Tuesday, March 19, 2024

The great unwinding

The failing battle for health and healthcare in these all too disunited states.

Ubiquitous threat: Microplastics discovered in every human placenta sample

This revelation underscores a growing environmental crisis, highlighting the pervasive infiltration of microplastics into the most intimate aspects of human life.

Under the microscope: DOJ’s antitrust probe into UnitedHealth’s market dominance

In a landmark move, the Biden DOJ initiates an antitrust investigation into UnitedHealth, unraveling the healthcare behemoth's sprawling influence and its implications for patient care and market competition.

Florida defies CDC in measles outbreak, telling parents it’s fine to send unvaccinated kids...

The CDC reported that childhood immunization rates hit a 10-year low.

Pharma CEOs grilled by Sanders: A standoff on drug pricing

"In a fiery Senate showdown, Senator Bernie Sanders challenges Big Pharma on exorbitant U.S. drug prices, revealing the stark divide between profit margins and patient access to essential medications."

Medicare launches first-ever drug price negotiations with pharmaceutical giants

"We are moving ahead to help people in spite of pharma's efforts to block negotiation in the courts."

Jury hands down $2.25 billion verdict to Bayer in Roundup weed killer case

John McKivison sued Bayer because he believes he developed cancer after using Roundup on his property for two decades,

21 bodycam videos caught the NYPD wrongly arresting Black kids on Halloween. Why can’t...

Police have frequently used that power to withhold footage, not only from the public, but also from civilian investigators.

Native American communities have the highest suicide rates, yet interventions are scarce

“It’s about time we had this line. To be able to connect people with resources and listen to them is something I can’t explain except that I was in a situation where I wanted someone to hear me and talk to.”

Why not control all drug prices?

Pharmaceutical companies are resisting public scrutiny and suing over modest drug price regulations. It’s past time to regulate their profiteering.